Association between glucose intolerance and psoriatic arthritis features

QR Code

Association between glucose intolerance and psoriatic arthritis features

Saved in:

Bibliographic Details
Main Authors:	Lihi Eder, Richard J Cook, Mu Yang, Sydney Thib, Sahil Koppikar, Shanti Mehta, Liana Dimitropoulos
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2025-06-01
Series:	RMD Open
Online Access:	https://rmdopen.bmj.com/content/11/2/e005709.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

IS PSORIATIC ARTHRITIS REALLY PSORIATIC?
by: Sh. F. Erdes
Published: (2014-12-01)

Psoriatic arthritis: pathogenetic features and innovative therapies
by: A. M. Lila, et al.
Published: (2019-01-01)

Psoriasis and Psoriatic Arthritis in ChildhoodPsoriasis and Psoriatic Arthritis in Childhood
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)

Rikkunshito prevents blood glucose intolerance in rats undergoing distal pancreatectomy
by: Hiroshi Kono, et al.
Published: (2025-12-01)

RETRACTED: The clinical features and course of psoriatic arthritis in children
by: S. N. Chebysheva, et al.
Published: (2014-06-01)

Features of the of psoriatic arthritis course in patients with hyperuricemia or gout
by: O.P. Bortkevych, et al.
Published: (2025-06-01)

Early psoriatic arthritis
by: E. Y. Loginova, et al.
Published: (2008-12-01)

Nail disease in psoriatic arthritis. Data from the Russian Psoriatic Arthritis Registry
by: E. E. Gubar, et al.
Published: (2021-10-01)

Features of medical and social expertise in ankylosing spondylitis and psoriatic arthritis
by: T. V. Dubinina, et al.
Published: (2023-02-01)

Dactylitis in psoriatic arthritis: clinical features, diagnosis, immunopathogenesis, and treatment
by: T. V. Korotaeva, et al.
Published: (2018-04-01)

Retraction of the article “The clinical features and course of psoriatic arthritis in children”
by: article Editorial
Published: (2021-10-01)

Therapy for psoriatic arthritis with infliximab
by: V V Badokin, et al.
Published: (2009-03-01)

Management of patients with psoriatic arthritis
by: Yulia Leonidovna Korsakova
Published: (2012-03-01)

Ixekizumab in the treatment of psoriatic arthritis
by: Yu. L. Korsakova, et al.
Published: (2024-12-01)

Axial involvement in psoriatic arthritis
by: E. E. Gubar, et al.
Published: (2022-12-01)

Standards of therapy of psoriatic arthritis
by: T V Korotaeva, et al.
Published: (2009-06-01)

Modern pharmacotherapy of psoriatic arthritis
by: Yu. L. Korsakova, et al.
Published: (2019-03-01)

Adalimumab in treatment of psoriatic arthritis
by: V. V. Badokin
Published: (2008-08-01)

Methotrexate in the treatment of rheumatoid arthritis and psoriatic arthritis
by: N. V. Chichasova, et al.
Published: (2021-06-01)

Difficult-to-treat psoriatic arthritis. Data from the All-Russian registry of patients with psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2024-10-01)

Carbohydrate intolerance
by: V. O. Kaybysheva, et al.
Published: (2018-08-01)

INTOLERANCE TO TOLERANCE
by: M. G. Pismanik
Published: (2017-12-01)

Severe rheumatoid arthritis with multiple baseline anti-inflammatory drugs intolerance
by: D. A. Kusevich, et al.
Published: (2016-12-01)

Psoriatic arthritis: clinical and ultrasound parallels
by: I. F. Fairushina, et al.
Published: (2020-09-01)

Involvement of the axial skeleton in psoriatic arthritis
by: E. E. Gubar, et al.
Published: (2017-03-01)

Clinical experience with apremilast for psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2018-09-01)

Current views on the pharmacotherapy of psoriatic arthritis
by: G. G. Taradin, et al.
Published: (2016-01-01)

Psoriasis and psoriatic arthritis: Topical issues
by: Yulia Leonidovna Korsakova
Published: (2012-09-01)

IMMUNE PATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS
by: S. V. Smirnova, et al.
Published: (2014-08-01)

Prognosis of pharmacotherapy effectiveness in psoriatic arthritis
by: Yu. L. Korsakova, et al.
Published: (2025-07-01)

Registers of psoriatic arthritis. Literature review
by: A. D. Koltakova
Published: (2019-05-01)

Etanercept (Enbrel) in the treatment of psoriatic arthritis
by: T V Korotaeva
Published: (2009-12-01)

CLINICAL HETEROGENEITY OF EARLY PSORIATIC ARTHRITIS
by: V. V. Badokin, et al.
Published: (2016-12-01)

Methotrexate in a psoriatic arthritis patient
by: K. V. Aleksanyan, et al.
Published: (2016-09-01)

Stage of morphological changes in psoriatic arthritis.
by: A. A. Buryanov, et al.
Published: (2020-03-01)

SPECIFIC FEATURES OF AXIAL SKELETON INVOLVEMENT IN EARLY PSORIATIC ARTHRITIS (The REMARCA TRIAL)
by: E. Yu. Loginova, et al.
Published: (2016-09-01)

Similarities and differences: disentangling the intersection between axial psoriatic arthritis and axial spondyloarthritis
by: Murat Torgutalp, et al.
Published: (2025-07-01)

Milk intolerances and rejection
Published: (1983)

Impact of Delay of Treatment With Disease‐Modifying Antirheumatic Drugs in Psoriatic Arthritis: The CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
by: Philip J. Mease, et al.
Published: (2025-06-01)

Pharmacoeconomic study of active psoriatic arthritis treatment
by: A. V. Rudakova, et al.
Published: (2025-02-01)